ClinicalTrialsFinder

Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma Clinical Trials in Oklahoma City, Oklahoma

1 recruitingOklahoma City, Oklahoma

Showing 1–1 of 1 trials

Recruiting
Phase 1

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Recurrent Endometrial CarcinomaRecurrent Ovarian High Grade Serous AdenocarcinomaRecurrent Ovarian Clear Cell Adenocarcinoma+6 more
National Cancer Institute (NCI)65 enrolled14 locationsNCT05950464